AGV-212

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAGV-212
Drug Alias Nameextracellular matrix protease inhibitor (Agrenvec)AGV-212
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionProtease inhibitors
TargetsProtease
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAgrenvec SL
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAgrenvec SL
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A